Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States

AIDS

Volumn 23, Issue 3, 2009, Pages 385-393

  Lanoy, Emilie ^a,b,c   Dores, Graça M ^a,d   Madeleine, Margaret M ^e   Toro, Jorge R ^a   Fraumeni Jr , Joseph F ^a   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

AIDS; Appendageal carcinoma; Epidemiology; Melanoma; Merkel cell carcinoma; Sebaceous carcinoma; Skin cancer

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; APPENDAGEAL SKIN CANCER; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CD4 LYMPHOCYTE COUNT; CHILD; DEMOGRAPHY; FEMALE; HETEROSEXUALITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MELANOMA; MERKEL CELL TUMOR; NEWBORN; PRIORITY JOURNAL; RACE; RADIATION EXPOSURE; SEBACEOUS CARCINOMA; SKIN CANCER; STANDARDIZED INCIDENCE RATIO; ULTRAVIOLET RADIATION; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADENOCARCINOMA, SEBACEOUS; ADOLESCENT; ADULT; CARCINOMA, MERKEL CELL; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 59849087355     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283213046     Document Type: Article

References (42)

1. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645-1654.
2. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285:1736-1745.
3. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370:59-67.
4. Harwood CA, McGregor JM, Swale VJ, Proby CM, Leigh IM, Newton R, et al. High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol 2003; 48:401-408.
5. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-1691.
6. Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77:574-579.
7. de Boer WA, Danner SA. HIV infection and squamous cell carcinoma of sun-exposed skin. AIDS 1990; 4:91.
8. Nguyen P, Vin-Christian K, Ming ME, Berger T. Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol 2002; 138:758-763.
9. Ibrahim SF, Brown MD. Tanning and cutaneous malignancy. Dermatol Surg 2008; 34:460-474.
10. Scotto J, Fears TR. The association of solar ultraviolet and skin melanoma incidence among Caucasians in the United States. Cancer Invest 1987; 5:275-283.
11. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN. Nonmelanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147:950-956.
12. Kripke ML. Ultraviolet radiation and immunology: something new under the sun - presidential address. Cancer Res 1994; 54:6102-6105.
13. Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM, et al. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 2008; 17:189-195.
14. Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, et al. Cutaneous human papillomaviruses found in sun- exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196:876-883.
15. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98:389-395.
16. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68:1717-1721.
17. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet 2002; 359:497-498.
18. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096-1100.
19. Harwood CA, Swale VJ, Bataille VA, Quinn AC, Ghali L, Pate I SV, et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 2001; 116:246-253.
20. Dover JS, Ashur ML, Kwan TH. Sebaceous adenoma in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1988; 124:489-490.
21. Frantz S, Greiner A, Schoen C, Langmann P, Klinker H. A sebaceous tumor in a patient with acquired immunodeficiency syndrome. Eur J Med Res 2002; 7:135-137.
22. Stockl FA, Dolmetsch AM, Codere F, Burnier MN Jr. Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome. Can J Ophthalmol 1995; 30:324-326.
23. Yen MT, Tse DT. Sebaceous cell carcinoma of the eyelid and the human immunodeficiency virus. Ophthal Plast Reconstr Surg 2000; 16:206-210.
24. Levi Z, Hazazi R, Kedar-Barnes I, Hodak E, Gal E, Mor E, et al. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. Am J Transplant 2007; 7:476-479.
25. Ponti G, Losi L, Di GC, Roncucci L, Pedroni M, Scarselli A, et al. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005; 103:1018-1025.
26. Ponti G, Losi L, Pedroni M, Lucci-Cordisco E, Di GC, Pellacani G, Seidenari S. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. J Invest Dermatol 2006; 126:2302-2307.
27. Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torré syndrome. 2008 [Epub ahead of print]
28. Fritz A, Percy C, Jack A, Sobin LH, Parkin MD. International classification of diseases for oncology; 2000.
29. LeBoit PE, Burg G, Weedom D, Sarasin D. World Health Organization classification of tumours. Pathology and genetics of skin tumours. Lyon: IARC Press; 2006.
30. Clifford GM, Polesel J, Rickenbach M, Dal ML, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97:425-432.
31. Dal ML, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003; 89:94-100.
32. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, KaldorJM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002; 16:1155-1161.
33. Newnham A, Harris J, Evans HS, Evans BG, Moller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer 2005; 92:194-200.
34. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148:728-736.
35. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153-158.
36. Lobo DV, Chu P, Crekin RC, Berger TG. Nonmelanoma skin cancers and infection with the human immunodeficiency virus. Arch Dermatol 1992; 128:623-627.
37. Maurer TA, Christian KV, Kerschmann RL, Berzin B, Palefsky JM, Payne D, et al. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol 1997; 133:577-583.
38. Overly WL, Jakubek DJ. Multiple squamous cell carcinomas and human immunodeficiency virus infection. Ann Intern Med 1987; 106:334.
39. Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005; 104:1505-1511.
40. Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, Retief JD, Bao Y, Newman S, et al. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53. Ophthalmology 1998; 105:497-506.
41. Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, Shimosato Y. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter. Mod Pathol 1994; 7:37-43.
42. Hayashi N, Furihata M, Ohtsuki Y, Ueno H. Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid. Virchows Arch 1994; 424:503-509.